28 results
Thumbnail

D3.339 - Severe β-lactam hypersensitivity phenotypes in routine care: anaphylaxis frequency in a 22-centre outpatient survey in China

Thumbnail

D3.340 - The importance of de-labeling contrast allergy în cardiology department - clinical case

Thumbnail

D3.341 - Alignment with International Anaphylaxis Management Guidelines in a Tertiary Referral Center in Central Asia: A Retrospective Clinical Audit

Thumbnail

D3.342 - Adverse Events of Biologic Therapies: A One-Year Retrospective Study

Thumbnail

D3.343 - Hereditary alpha-tryptasemia: clinical variability and anaphylaxis triggers in six genetically confirmed cases

Thumbnail

D3.344 - Rapid Desensitization to Iohexol Following Iopamidol-Induced Anaphylaxis Prior to Urgent Coronary Angiography

Thumbnail

D3.345 - Anaphylactic Shock: Clinical Analysis of 8 Cases with Post-Hospital Outpatient Follow-Up

Thumbnail

D3.346 - From Anaphylaxis to Oral Allergy Syndrome: Multiple Seed Hypersensitivity in a Single Pediatric Patient

Thumbnail

D3.347 - Idiopathic Anaphylaxis: A Diagnostic Challenge

Thumbnail

D3.348 - Alpha‑gal Syndrome in Young People: A Call for Public Health Awareness in Tick‑Endemic Areas of Scotland and North East England

Thumbnail

D3.349 - Takotsubo cardiomyopathy triggered by anaphylaxis after a honey bee sting, forming ATAK complex: a rare case report

Thumbnail

D3.351 - A case of Kounis syndrome in idiopathic anaphylaxis and indolent systemic mastocytosis

Thumbnail

D3.352 - Long-term analytical stability of ImmunoCAP tryptase supports enduring clinical interpretation thresholds

Thumbnail

D3.353 - Clinical Characteristics and Triggers of Pediatric Anaphylaxis Cases: A Retrospective Single-Center Experience

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use